Primary sclerosing cholangitis

Autor: Marina G Silveira, Keith D Lindor

Publikováno v: Canadian Journal of Gastroenterology, Vol 22, Iss 8, Pp 689-698 (2008)

Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease characterized by inflammation and fibrosis of the bile ducts, resulting in end-stage liver disease and reduced life expectancy. PSC primarily affects young and middle-aged me

Externí odkaz: https://doaj.org/article/3d0a59bbd0764b9e9561875d56d47f98

Medical Management of Chronic Cholestatic Liver Diseases

Autor: Andrea A Gossard, Keith D Lindor

Publikováno v: Canadian Journal of Gastroenterology, Vol 14, Iss Suppl D, Pp 93D-98D (2000)

The purpose of the present review is to discuss the diagnosis and management of cholestatic liver diseases. Differential diagnoses to consider are described, including causes of extrahepatic biliary obstruction such as gallstones, strictures, extrabi

Externí odkaz: https://doaj.org/article/237d675d51ba4ff8bd6581bd9dc1342e

Potential Association of Doxycycline With the Onset of Primary Sclerosing Cholangitis: A Case Series

Autor: Kenneth L. Cox, Keith D. Lindor, Ahmad H. Ali, James Gage Buness, James H. Tabibian, Cynthia W Buness

Publikováno v: American Journal of Therapeutics. 29:e437-e443

Background Primary sclerosing cholangitis (PSC) is linked to inflammatory bowel diseases (IBD). Evidence suggests an association between the gut microbiome and PSC. However, the putative relationship between exposure to antibiotics and onset of PSC h

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10c8a6ca2104c2b7564a6fdeff63a90a
https://doi.org/10.1097/mjt.0000000000001065

Geographical region and clinical outcomes of patients with primary biliary cholangitis from Western Europe

Autor: Carla F, Murillo Perez, Alessio, Gerussi, Palak J, Trivedi, Christophe, Corpechot, Adriaan J, van der Meer, Pier, Maria Battezzati, Keith D, Lindor, Frederik, Nevens, Kris V, Kowdley, Tony, Bruns, Nora, Cazzagon, Annarosa, Floreani, Atsushi, Tanaka, Xiong, Ma, Andrew L, Mason, Aliya, Gulamhusein, Cyriel Y, Ponsioen, Marco, Carbone, Ana, Lleo, Marlyn J, Mayo, George N, Dalekos, Nikolaos K, Gatselis, Douglas, Thorburn, Xavier, Verhelst, Albert, Parés, Harry L A, Janssen, Gideon M, Hirschfield, Bettina E, Hansen, Pietro, Invernizzi, Willem J, Lammers

Publikováno v: European Journal of Gastroenterology and Hepatology, 35(1), 112-119. Lippincott Williams & Wilkins

Background and aims The are geographic variations in the incidence and prevalence of primary biliary cholangitis (PBC). The aim was to explore whether clinical outcomes of patients within Western Europe differ according to geographical region. Method

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::4fb0ee5829af4ca3a1704b8ba980d034
https://pure.eur.nl/en/publications/b7aa98f2-a19b-447a-b5ba-03b27f7812eb

Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls

Autor: C. Fiorella Murillo Perez, Holly Fisher, Shaun Hiu, Dorcas Kareithi, Femi Adekunle, Tracy Mayne, Elizabeth Malecha, Erik Ness, Adriaan J. van der Meer, Willem J. Lammers, Palak J. Trivedi, Pier Maria Battezzati, Frederik Nevens, Kris V. Kowdley, Tony Bruns, Nora Cazzagon, Annarosa Floreani, Andrew L. Mason, Albert Parés, Maria-Carlota Londoño, Pietro Invernizzi, Marco Carbone, Ana Lleo, Marlyn J. Mayo, George N. Dalekos, Nikolaos K. Gatselis, Douglas Thorburn, Xavier Verhelst, Aliya Gulamhusein, Harry L.A. Janssen, Rachel Smith, Steve Flack, Victoria Mulcahy, Michael Trauner, Christopher L. Bowlus, Keith D. Lindor, Christophe Corpechot, David Jones, George Mells, Gideon M. Hirschfield, James Wason, Bettina E. Hansen, Richard Sturgess, Christopher Healey, Anton Gunasekera, Yiannis Kallis, Gavin Wright, Thiriloganathan Mathialahan, Richard Evans, Jaber Gasem, David Ramanaden, Emma Ward, Mahesh Bhalme, Paul Southern, James Maggs, Mohamed Yousif, Brijesh Srivastava, Matthew Foxton, Carole Collins, Yash Prasad, Francisco Porras-Perez, Tom Yapp, Minesh Patel, Roland Ede, Martyn Carte, Konrad Koss, Prayman Sattianayagam, Charles Grimley, Jude Tidbury, Dina Mansour, Matilda Beckley, Coral Hollywood, John Ramag, Harriet Gordon, Joanne Ridpath, Bob Grover, George Abouda, Ian Rees, Mark Narain, Imroz Salam, Paul Banim, Debasish Das, Helen Matthews, Faiyaz Mohammed, Rebecca Jones, Sambit Sen, George Bird, Martin Prince, Geeta Prasad, Paul Kitchen, John Hutchinson, Prakash Gupta, Amir Shah, Subrata Saha, Katharine Pollock, Stephen Barclay, Natasha McDonald, Simon Rushbrook, Robert Przemioslo, Andrew Millar, Steven Mitchell, Andrew Davis, Asifabbas Naqvi, Tom Lee, Stephen Ryder, Jane Collier, Matthew Cramp, Richard Aspinal, Jonathan Booth, Earl Williams, Hyder Hussaini, John Christie, Tehreem Chaudhry, Stephen Mann, Aftab Ala, Julia Maltby, Chris Corbett, Saket Singhal, Barbara Hoeroldt, Jeff Butterworth, Andrew Douglas, Rohit Sinha, Simon Panter, Jeremy Shearman, Gary Bray, Michael Roberts, Daniel Forton, Nicola Taylor, Wisam Jafar, Matthew Cowan, Chin Lye Ch'ng, Mesbah Rahman, Emma Wesley, Sanjiv Jain, Aditya Mandal, Mark Wright, Palak Trivedi, Fiona Gordon, Esther Unitt, Andrew Austin, Altaf Palegwala, Vishwaraj Vemala, Andrew Higham, Jocelyn Fraser, Andy Li, Subramaniam Ramakrishnan, Alistair King, Simon Whalley, Ian Gee, Richard Keld, Helen Fellows, James Gotto, Charles Millson

Publikováno v: Gastroenterology, 163(6), 1630-1642.e3. W.B. Saunders

BACKGROUND & AIMS: The Primary Biliary Cholangitis (PBC) Obeticholic Acid (OCA) International Study of Efficacy (POISE) randomized, double-blind, placebo-controlled trial demonstrated that OCA reduced biomarkers associated with adverse clinical outco

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::971d07164b504c479b9334f7d6369923
https://lirias.kuleuven.be/handle/20.500.12942/703480